FDA applicant
Ameditech, Inc.
FDA records 14 decisions for Ameditech, Inc. (San Diego, CA) from 2001 to 2011: 14 510(k) clearances. Most are in product codes DKZ (Enzyme Immunoassay, Amphetamine) and DJG (Enzyme Immunoassay, Opiates). Its devices cite 6 predicates, 6 of them its own earlier devices. 87 recalls are linked to its devices.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Ameditech, Inc.’s devices, and how often a recall has named them.
FDA decisions per year
2in 2011
2026 so far, outlined.
Recalls per year
3in 2020
Class I Class II/III not classified
Planning a device like Ameditech, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report